POZEN Logo
Print Page   Close Window

Press Release

POZEN to Present at the Piper Jaffray 23rd Annual Healthcare Conference

CHAPEL HILL, N.C.--(BUSINESS WIRE)--Nov. 17, 2011--

POZEN Inc. (NASDAQ: POZN), a pharmaceutical company committed to transforming medicine that transforms lives, announced today that John R. Plachetka, Pharm.D., the Company’s Chairman, President and Chief Executive Officer, will present at the Piper Jaffray 23rd Annual Healthcare Conference on Wednesday, November 30, 2011 at 2:30 p.m. (ET), at The New York Palace Hotel. Dr. Plachetka’s presentation will be webcast and available for replay on POZEN’s home page at www.pozen.com.

About POZEN

POZEN Inc. is a progressive pharmaceutical company that is transforming how the healthcare industry addresses unmet medical needs. By utilizing a unique in-source model and focusing on integrated therapies, POZEN has successfully developed and obtained FDA approval of two self-invented products in two years – something almost no other small pharmaceutical company has done. Funded by these two milestone/royalty streams, POZEN is now creating a portfolio of cost-effective, evidence-based integrated aspirin therapies designed to enable the full power of aspirin by reducing its GI damage.

The Company’s common stock is traded on The NASDAQ Global Market under the symbol “POZN”. For more detailed company information, including copies of this and other press releases, please visit www.pozen.com.

Source: POZEN Inc.

POZEN Inc.
Bill Hodges, 919-913-1030
Chief Financial Officer
or
Stephanie Bonestell, 919-913-1030
Manager, Investor Relations & Public Relations